Cargando…
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
BACKGROUND AND AIMS: Endothelial dysfunction and portal hypertension (PH) are reflected by increased von Willebrand factor antigen (VWF-Ag) levels in advanced chronic liver disease (ACLD). This study investigated VWF release and cleavage and their association with PH and clinical outcomes. METHODS:...
Autores principales: | Simbrunner, Benedikt, Villesen, Ida Falk, Scheiner, Bernhard, Paternostro, Rafael, Schwabl, Philipp, Stättermayer, Albert Friedrich, Marculescu, Rodrig, Pinter, Matthias, Quehenberger, Peter, Trauner, Michael, Karsdal, Morten, Lisman, Ton, Reiberger, Thomas, Leeming, Diana Julie, Mandorfer, Mattias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661794/ https://www.ncbi.nlm.nih.gov/pubmed/37605068 http://dx.doi.org/10.1007/s12072-023-10577-y |
Ejemplares similares
-
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis
por: Simbrunner, Benedikt, et al.
Publicado: (2020) -
Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2020) -
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019) -
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2022) -
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)